Silencing of LINC00707 suppresses cell proliferation, migration, and invasion of osteosarcoma cells by modulating miR-338-3p/AHSA1 axis

Osteosarcoma is the most common type of primary malignant tumor of the bone, with a high metastatic rate and poor prognosis. Therefore, it is important to further elucidate the molecular mechanisms involved in the development of osteosarcoma and explore new molecular therapeutic targets. Long interg...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhang Xiao-rong, Shao Jian-li, Li Heng, Wang Liang
Formato: article
Lenguaje:EN
Publicado: De Gruyter 2021
Materias:
Acceso en línea:https://doaj.org/article/9fa619a8a1b0496da13efb5f1d6ad8a7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9fa619a8a1b0496da13efb5f1d6ad8a7
record_format dspace
spelling oai:doaj.org-article:9fa619a8a1b0496da13efb5f1d6ad8a72021-12-05T14:10:41ZSilencing of LINC00707 suppresses cell proliferation, migration, and invasion of osteosarcoma cells by modulating miR-338-3p/AHSA1 axis2391-541210.1515/biol-2021-0070https://doaj.org/article/9fa619a8a1b0496da13efb5f1d6ad8a72021-07-01T00:00:00Zhttps://doi.org/10.1515/biol-2021-0070https://doaj.org/toc/2391-5412Osteosarcoma is the most common type of primary malignant tumor of the bone, with a high metastatic rate and poor prognosis. Therefore, it is important to further elucidate the molecular mechanisms involved in the development of osteosarcoma and explore new molecular therapeutic targets. Long intergenic nonprotein-coding RNA 707 (LINC00707) is an oncogenic gene in several cancers. In this study, we further clarified its role and regulatory mechanism in osteosarcoma. We found that LINC00707 levels are significantly higher in the osteosarcoma cell lines SW 1353, HOS, U-2 OS, MG-63, and Saos-2 compared to those in human fetal osteoblastic cell line hFOB1.19. LINC00707 silencing suppressed cell proliferation, migration, and invasion of MG-63 and Saos-2 cells. Moreover, LINC00707 can act as a competitive endogenous RNA of miR-338-3p, and miR-338-3p inhibitor and AHSA1 overexpression alleviated the effect of LINC00707 silencing. In conclusion, we demonstrated high expression of LINC00707 in osteosarcoma cell lines and that silencing LINC00707 suppresses cell proliferation, migration, and invasion by targeting the miR-338-3p/AHSA1 axis in MG-63 and Saos-2 cells. These findings suggest that LINC00707 may serve as a potential target for osteosarcoma treatment.Zhang Xiao-rongShao Jian-liLi HengWang LiangDe Gruyterarticlelinc00707osteosarcomacernamir-338-3pahsa1Biology (General)QH301-705.5ENOpen Life Sciences, Vol 16, Iss 1, Pp 728-736 (2021)
institution DOAJ
collection DOAJ
language EN
topic linc00707
osteosarcoma
cerna
mir-338-3p
ahsa1
Biology (General)
QH301-705.5
spellingShingle linc00707
osteosarcoma
cerna
mir-338-3p
ahsa1
Biology (General)
QH301-705.5
Zhang Xiao-rong
Shao Jian-li
Li Heng
Wang Liang
Silencing of LINC00707 suppresses cell proliferation, migration, and invasion of osteosarcoma cells by modulating miR-338-3p/AHSA1 axis
description Osteosarcoma is the most common type of primary malignant tumor of the bone, with a high metastatic rate and poor prognosis. Therefore, it is important to further elucidate the molecular mechanisms involved in the development of osteosarcoma and explore new molecular therapeutic targets. Long intergenic nonprotein-coding RNA 707 (LINC00707) is an oncogenic gene in several cancers. In this study, we further clarified its role and regulatory mechanism in osteosarcoma. We found that LINC00707 levels are significantly higher in the osteosarcoma cell lines SW 1353, HOS, U-2 OS, MG-63, and Saos-2 compared to those in human fetal osteoblastic cell line hFOB1.19. LINC00707 silencing suppressed cell proliferation, migration, and invasion of MG-63 and Saos-2 cells. Moreover, LINC00707 can act as a competitive endogenous RNA of miR-338-3p, and miR-338-3p inhibitor and AHSA1 overexpression alleviated the effect of LINC00707 silencing. In conclusion, we demonstrated high expression of LINC00707 in osteosarcoma cell lines and that silencing LINC00707 suppresses cell proliferation, migration, and invasion by targeting the miR-338-3p/AHSA1 axis in MG-63 and Saos-2 cells. These findings suggest that LINC00707 may serve as a potential target for osteosarcoma treatment.
format article
author Zhang Xiao-rong
Shao Jian-li
Li Heng
Wang Liang
author_facet Zhang Xiao-rong
Shao Jian-li
Li Heng
Wang Liang
author_sort Zhang Xiao-rong
title Silencing of LINC00707 suppresses cell proliferation, migration, and invasion of osteosarcoma cells by modulating miR-338-3p/AHSA1 axis
title_short Silencing of LINC00707 suppresses cell proliferation, migration, and invasion of osteosarcoma cells by modulating miR-338-3p/AHSA1 axis
title_full Silencing of LINC00707 suppresses cell proliferation, migration, and invasion of osteosarcoma cells by modulating miR-338-3p/AHSA1 axis
title_fullStr Silencing of LINC00707 suppresses cell proliferation, migration, and invasion of osteosarcoma cells by modulating miR-338-3p/AHSA1 axis
title_full_unstemmed Silencing of LINC00707 suppresses cell proliferation, migration, and invasion of osteosarcoma cells by modulating miR-338-3p/AHSA1 axis
title_sort silencing of linc00707 suppresses cell proliferation, migration, and invasion of osteosarcoma cells by modulating mir-338-3p/ahsa1 axis
publisher De Gruyter
publishDate 2021
url https://doaj.org/article/9fa619a8a1b0496da13efb5f1d6ad8a7
work_keys_str_mv AT zhangxiaorong silencingoflinc00707suppressescellproliferationmigrationandinvasionofosteosarcomacellsbymodulatingmir3383pahsa1axis
AT shaojianli silencingoflinc00707suppressescellproliferationmigrationandinvasionofosteosarcomacellsbymodulatingmir3383pahsa1axis
AT liheng silencingoflinc00707suppressescellproliferationmigrationandinvasionofosteosarcomacellsbymodulatingmir3383pahsa1axis
AT wangliang silencingoflinc00707suppressescellproliferationmigrationandinvasionofosteosarcomacellsbymodulatingmir3383pahsa1axis
_version_ 1718371855632433152